Christopher J Clarke

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Basal Cell Carcinoma

Artificial Intelligence

Cell Cycle Arrest

Immune Response

Top Venues

Nature communications

Cell death & disease

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick Niekamp, Felix Scharte, Tolulope Sokoya, Laura Vittadello, Yeongho Kim, Yongqiang Deng, Elisabeth Südhoff, Angelika Hilderink, Mirco Imlau, Christopher J Clarke, Michael Hensel, Christopher G Burd, Joost C M Holthuis
Ca 2+ -activated sphingomyelin scrambling and turnover mediate ESCRT-independent lysosomal repair. Nature communications 13 (1) (2022)
Magali Trayssac, Christopher J Clarke, Jeffrey L Stith, Justin M Snider, Naomi Newen, Christopher R Gault, Yusuf A Hannun, Lina M Obeid
Targeting sphingosine kinase 1 (SK1) enhances oncogene-induced senescence through ceramide synthase 2 (CerS2)-mediated generation of very-long-chain ceramides. Cell death & disease 12 (1) (2021)
Anne Montfort, Florie Bertrand, Julia Rochotte, Julia Gilhodes, Thomas Filleron, Jean Milhès, Carine Dufau, Caroline Imbert, Joëlle Riond, Marie Tosolini, Christopher J Clarke, Florent Dufour, Andrei A Constantinescu, Nilton De França Junior, Virginie Garcia, Michel Record, Pierre Cordelier, Pierre Brousset, Philippe Rochaix, Sandrine Silvente-Poirot, Nicole Therville, Nathalie Andrieu-Abadie, Thierry Levade, Yusuf A Hannun, Hervé Benoist, Nicolas Meyer, Olivier Micheau, Céline Colacios, Bruno Ségui
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy. Cancer immunology research 9 (5) (2021)